2026-06-09
Best Buy is the largest specialty consumer-electronics retailer in North America, operating 1,117 stores across the United States and Canada. Founded in 1966, the company sells consumer electronics, appliances, and technology products through its retail network and online platform. It supplements product sales with high-margin services: the Geek Squad handles installation, repair, and support, while Best Buy Health targets the fast-growing connected-senior-care market. Revenue for FY2026 was $41.7 billion. The business generates meaningful free cash flow, pays a growing dividend yielding above 5%, and has steadily bought back shares. However, it faces a structural headwind: consumers increasingly buy electronics online directly from manufacturers and through Amazon, compressing Best Buy’s role as a physical intermediary.
Key Financial Data & Valuation Inputs
Income Statement Summary (FY2022–FY2026, $M)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | 51,761 | 46,298 | 43,452 | 41,528 | 41,691 |
| Gross Profit | 11,640 | 9,912 | 9,603 | 9,385 | 9,373 |
| Gross Margin | 22.5% | 21.4% | 22.1% | 22.6% | 22.5% |
| Operating Income | 3,039 | 1,795 | 1,574 | 1,262 | 1,389 |
| Operating Margin | 5.9% | 3.9% | 3.6% | 3.0% | 3.3% |
| Net Income | 2,454 | 1,419 | 1,241 | 927 | 1,069 |
| EPS (Diluted) | 9.84 | 6.29 | 5.68 | 4.28 | 5.04 |
| Free Cash Flow | 2,515 | 894 | 675 | 1,392 | 1,258 |
| EBITDA | 3,908 | 2,713 | 2,497 | 2,128 | 2,220 |
Balance Sheet Highlights (FY2026, $M)
| Item | Value ($M) |
|---|---|
| Cash & Equivalents | 1,738 |
| Total Current Assets | 8,504 |
| Total Current Liabilities | 7,679 |
| Current Ratio | 1.11x |
| Total Debt (incl. leases) | 4,133 |
| Long-Term Debt (ex-leases) | 1,165 |
| Net Debt | 2,395 |
| Shareholders’ Equity | 2,964 |
| Total Assets | 14,670 |
| Goodwill | 790 |
Cash Flow Summary (FY2026, $M)
| Item | Value ($M) |
|---|---|
| Operating Cash Flow | 1,962 |
| Capital Expenditures | -704 |
| Free Cash Flow | 1,258 |
| Dividends Paid (est.) | ~800 |
| FCF Yield (at $75.13) | ~8.0% |
Valuation & Ratio Summary
| Metric | Value | Commentary |
|---|---|---|
| Current Price | $75.13 | As provided |
| Trailing P/E | 14.9x | FY2026 EPS $5.04 |
| Forward P/E | ~11.4–12.1x | FY27 est. EPS ~$6.20–$6.60 |
| EPS Growth (5-yr avg) | ~-12% (declining) | EPS peaked at $9.84 in FY2022 |
| EV/EBITDA | ~5.8x | Very cheap vs. sector |
| Price/FCF | ~12.5x | Attractive; FCF yield ~8% |
| Debt/Equity | 1.39x | Elevated; mostly operating leases |
| ROE | 37% | High, but inflated by low equity base |
| ROIC | 24.8% | Strong capital efficiency |
| Dividend Yield | 5.1% | Well-covered by FCF |
| Beta | 1.37 | Above-market volatility |
PE, PEG, PEGY Summary
| Ratio | Value | Notes |
|---|---|---|
| P/E (Trailing) | 14.9x | Based on FY2026 EPS of $5.04 |
| P/E (Forward) | 11.4x | Based on midpoint FY27 guidance of $6.40 |
| PEG Ratio | N/M (negative) | 5-yr EPS growth is negative; PEG not meaningful |
| PEGY Ratio | ~1.25x | Forward P/E / (EPS growth + dividend yield); using FY26-to-FY27 EPS recovery of ~27% gives PEGY ~0.75x — highly favorable if recovery is sustained; using normalized 2–3% long-term growth gives PEGY ~1.5x |
PEGY note: PEGY = P/E / (EPS Growth Rate + Dividend Yield %). A PEGY below 1.0 is generally considered undervalued by Peter Lynch’s framework. On a normalized growth basis BBY sits near 1.0–1.5x, which is borderline. On a near-term recovery basis the ratio is highly attractive.
Investment Q&A Analysis
| Question | Answer |
|---|---|
| Is the business model simple and sustainable? | Simple: yes. Sustainable: partially. Best Buy is a physical and digital retailer of consumer electronics and appliances, supplemented by Geek Squad services. The model is straightforward. The sustainability question is more nuanced — footfall-driven electronics retail faces secular pressure from e-commerce and direct-to-consumer manufacturer strategies. However, BBY has proven more resilient than most expected, stabilizing revenues near $41–42B. Services (Geek Squad, Best Buy Health) add a recurring-revenue dimension. Sustainability is conditional on the omnichannel pivot succeeding. |
| Intrinsic Values, PE, PEG, PEGY | DCF Intrinsic Value: ~$72–82 (base case). MEV (Multiple-based): ~$68–85. Trailing P/E: 14.9x. Forward P/E: 11.4x. PEG: not meaningful (negative 5-yr EPS trend). PEGY: ~0.75–1.5x depending on growth assumption. See Step 5 for full scenario breakdown. |
| Durable competitive advantage (moat)? | Narrow moat. Best Buy’s advantages include scale (largest U.S. electronics chain), vendor relationships that allow exclusive launches and favourable terms, Geek Squad’s brand recognition in tech support, and physical showroom network that Amazon cannot replicate cheaply. However, these are not wide moats: Amazon already exceeds BBY in electronics e-commerce, and manufacturer direct-to-consumer programmes chip away at the middleman’s relevance. The moat is shrinking slowly, not collapsing. |
| Competitors and competitive positioning | Primary competitors: Amazon (dominant online), Walmart, Costco, Target (in-store electronics), Apple Stores (premium), and manufacturer websites (Samsung, LG, Sony). BBY is the only national specialist electronics retailer left standing after the failures of Circuit City and RadioShack, giving it de facto leadership in the physical channel. Its 1,117 stores serve as showrooms even when purchases complete online, giving vendors an incentive to maintain the relationship. |
| Management competence and alignment | CEO Corie Barry has navigated a difficult post-pandemic normalisation creditably. Share count has fallen from 247M (FY2022) to 209M (FY2026) through consistent buybacks. The dividend has grown every year. Guidance for FY26 adjusted EPS of $6.20–$6.60 is credible given FY26 actual of $5.04 (which included a goodwill impairment). Compensation includes stock-based incentives. No empire-building acquisitions of note. The Lively health-tech acquisition is small and strategically sensible. Management scores above average for a mature retailer. |
| Is the stock undervalued vs. intrinsic value? | Marginally. At $75.13 the stock trades at approximately par with the base-case DCF of $72–82. It is not deeply discounted. The margin of safety is thin at this price, which is why the verdict is HOLD rather than aggressive BUY. A pullback toward $55–62 would offer compelling value. The forward P/E of ~11.4x is low in absolute terms but reflects legitimate structural risk. |
| Capital efficiency | ROIC of 24.8% is high for retail, reflecting the asset-light nature of a lease-based store network. The company does not need large capital outlays to maintain competitive position. Capex of $704M in FY2026 (down from $930M in FY2023) represents roughly 1.7% of revenue, manageable for a business of this scale. The decline in capex is consistent with store-count discipline rather than underinvestment. |
| Free cash flow generation | FCF of $1.26B in FY2026 and $1.39B in FY2025 is solid. FCF yield at the current price is approximately 8%, which is high by any standard. FCF has been volatile (collapsed to $675M in FY2024 during a working-capital squeeze) but has recovered. The payout ratio on FCF is approximately 64% including dividends, leaving room for buybacks. Owner earnings are positive and growing modestly. |
| Balance sheet strength | Adequate but not fortress-grade. Current ratio of 1.11x provides thin liquidity cover. Long-term financial debt of $1.165B is manageable relative to annual EBITDA of $2.2B (Debt/EBITDA ~0.5x ex-leases). Including operating leases, total debt/EBITDA rises to ~1.9x, which is elevated but typical for large-format retail. Goodwill of $790M (down from $1.38B after FY2025 impairment) reduced a previous red flag. No pension overhang of significance. |
| Revenue and earnings consistency | Inconsistent. Revenue has declined every year from FY2022 ($51.8B) to FY2025 ($41.5B), recovering only marginally to $41.7B in FY2026. EPS fell from $9.84 to $4.28 over the same period. FY2026 shows the first net income recovery (+15%). The picture is of a business that peaked during the pandemic-driven electronics super-cycle and is now finding a new, lower baseline. The key investment question is whether this baseline is now stable. |
| Margin of safety | At $75.13 the margin of safety is approximately 5–10% vs. base-case intrinsic value. This is insufficient for a high-conviction long-term buy. Peter Lynch’s general principle of buying at a 30–40% discount is not met at this price. If the base-case IV is ~$78, a 30% discount would require a price near $55. The stock is fairly priced, not obviously cheap. |
| Biggest risks | 1. Structural revenue decline as Amazon and manufacturer D2C channels grow. 2. Consumer cyclicality: electronics is discretionary, hit hard in recessions. 3. Tariff risk: large electronics imports from Asia face tariff uncertainty in 2025–2026. 4. Dividend sustainability if FCF falls below $1B. 5. Goodwill impairment risk on remaining $790M. 6. AI/retail disruption — Best Buy Health faces competition from well-funded health-tech firms. |
| Share dilution or bad acquisitions? | No dilution — shares outstanding have declined steadily from 249M (FY2022) to 209M (FY2026), a 16% reduction. No significant dilutive acquisitions. The Lively and Current Health acquisitions were small tuck-ins in the health space, aligned with the strategic pivot. Stock-based compensation of ~$139M/year is modest relative to net income. Management passes the dilution test cleanly. |
| Cyclical or stable? Recession performance? | Moderately cyclical. Consumer electronics is discretionary: in a recession, consumers delay TV and laptop upgrades. However, certain categories (home office, appliance replacement) are less deferrable. Best Buy’s FY2023–FY2025 revenue decline partly reflects post-pandemic normalisation rather than pure recession impact. In the 2008–2009 recession, BBY held up better than most discretionary retailers. Services revenue provides modest counter-cyclical cushion. Beta of 1.37 confirms above-average market sensitivity. |
| What would this company look like in 5–10 years? | Most likely scenario: Best Buy operates a smaller but more profitable store base (perhaps 900–1,000 stores), with services and health tech contributing 15–20% of gross profit. Revenue stabilizes around $38–44B. The stock generates returns primarily through dividends and buybacks rather than growth. An optimistic scenario sees Best Buy Health becoming a $3–5B revenue segment. A pessimistic scenario sees continued revenue erosion and dividend cuts. The company is likely to survive but unlikely to be a high-growth compounder. |
| Would you buy if the market closed for 5 years? | Cautiously yes — if purchased at or below $62. The combination of a 5%+ dividend yield and ongoing buybacks means a patient investor collects roughly 7–8% annually in capital return alone, even if the stock price is flat. The business is not going to zero — it is the category leader in physical electronics retail with a services business that has genuine value. But the stock must be bought at a price that embeds this uncertainty. |
| What does PEGY indicate? | PEGY (Price/Earnings-to-Growth plus Yield) is Peter Lynch’s refinement of PEG that accounts for dividend income. A PEGY below 1.0 suggests the stock is undervalued relative to its total return profile. Using FY27 forward P/E of ~11.4x, a 5% dividend yield, and a conservative 2% long-term earnings growth, PEGY is approximately 1.5x. Using the near-term recovery growth (~20%), PEGY falls to ~0.65x. This wide range makes PEGY less decisive here; the key variable is whether the EPS recovery is durable. |
| Capital reinvestment vs. shareholder returns | Best Buy is predominantly a capital-return story rather than a reinvestment story. FCF allocation in FY2026: ~$800M in dividends, ~$500M in buybacks, ~$704M in capex. The business does not have high-return reinvestment opportunities at scale. Management wisely channels excess cash to shareholders rather than making dilutive acquisitions. This is rational given the maturity of the core business. The Best Buy Health bet is the one meaningful reinvestment play, with a long payoff horizon. |
| Why is this stock mispriced, or is it correctly priced? | The market is pricing in permanent structural decline: the stock has de-rated sharply from a P/E above 20x in 2021 to below 15x today. The market may be missing three things: (1) the durability of FCF at the new lower revenue base; (2) the optionality in Best Buy Health; (3) the ongoing share count reduction compounding per-share metrics. The bear case is already reflected in the multiple. A stabilization of revenue near $41–43B could cause a re-rating to 15–17x earnings, implying 30–40% upside from the right entry price. |
| Thesis assumptions and what would disprove them | Key assumptions: revenue stabilizes near $41–43B; FCF remains above $1B; dividend is maintained; Best Buy Health grows. Thesis would be disproved by: revenue dropping below $38B, FCF falling below $700M, dividend cut, Amazon aggressively entering appliance installation services, or a severe recession that collapses consumer electronics demand for 18+ months. |
| Portfolio fit | Best Buy fits best as a value/income holding in a diversified portfolio, not as a core growth position. It provides above-average dividend yield, some defensive characteristics through services revenue, and modest buyback support. It should not exceed 3–5% of a growth-oriented portfolio due to structural headwinds. Investors seeking capital appreciation should look elsewhere; those seeking yield-plus-modest-upside may find it interesting at the right price. |
| Intrinsic value summary and BUY / HOLD / SELL verdict | Base-case IV: ~$78. Bear IV: ~$52. Bull IV: ~$108. At $75.13, the stock is roughly fairly valued. HOLD at current price. A strong BUY entry is at or below $60. The target price for 9% annualised return over 16 years from the base case is approximately $54–60 (see Step 6). Do not chase at $75. |
Intrinsic Value Calculations
A. Discounted Cash Flow (DCF)
Inputs used:
| Input | Value |
|---|---|
| Base FCF (FY2026) | $1,258M |
| Shares Outstanding | 209.1M |
| FCF per Share (base) | $6.02 |
| FCF Growth Rate (Years 1–5) | 2% (conservative, reflecting stabilisation) |
| FCF Growth Rate (Years 6–10) | 1% |
| Terminal Growth Rate | 0.5% (mature business with structural headwinds) |
| Discount Rate (WACC) | 9.5% (reflecting beta 1.37, modest leverage) |
| Net Debt per Share | -$11.45 |
DCF Result: ~$72–82 per share (base case). Sensitivity to discount rate is high: at 8.5% WACC the value rises to ~$88; at 10.5% it falls to ~$62.
B. Market-Equivalent Valuation (MEV / Multiple-Based)
| Method | Multiple Applied | Metric | Implied Value |
|---|---|---|---|
| P/E (sector avg ~15x) | 15x | FY2026 EPS $5.04 | $75.60 |
| EV/EBITDA (comp avg ~7x) | 7x | EBITDA $2,220M | ~$68 |
| Price/FCF (retail avg ~14x) | 14x | FCF/sh $6.02 | $84 |
| Forward P/E (FY27 est ~14x) | 14x | FY27E EPS $6.40 | $89.60 |
MEV blended estimate: ~$75–85.
Valuation Values Used vs. Ignored
| Used | Ignored / Less Weighted |
|---|---|
| FY2026 FCF ($1,258M), EPS ($5.04), EBITDA ($2,220M), WACC 9.5%, shares 209M, net debt $2,395M, terminal growth 0.5% | Book value per share (distorted by lease liabilities), trailing PEG (EPS trend is negative, metric not meaningful), price-to-sales (thin margin business makes P/S less informative), goodwill-adjusted book value |
Weighted SWOT Analysis
Strengths (Weight: 30%)
- Category leader: only national specialist electronics chain
- Strong FCF yield (~8%) and 5%+ dividend yield
- Geek Squad: trusted brand with high switching costs in tech support
- Consistent share buybacks reducing float by ~2% annually
- ROIC of 24.8%; capital-light lease model
- Vendor relationships: exclusive launches, display partnerships (Apple, Samsung)
- Best Buy Health: emerging recurring revenue stream
Weaknesses (Weight: 25%)
- Revenue declined 20% from FY2022 peak ($51.8B to $41.5B)
- Operating margin thin at 3.3%; limited pricing power
- Elevated total debt including $2.3B in operating leases
- Goodwill impairment in FY2025 signals overpaid acquisitions
- High beta (1.37): volatile in downturns
- Negative 5-yr EPS growth trend; PEG not meaningful
Opportunities (Weight: 25%)
- AI-driven device refresh cycle (2025–2028): PCs, TVs, appliances
- Best Buy Health could become a $3–5B revenue segment by 2030
- Store-as-a-service model (vendor showrooms generating rent/data)
- Expanded Geek Squad enterprise and B2B services
- Revenue stabilisation allows multiple re-rating to 15–17x
- Further share buybacks at depressed valuations
Threats (Weight: 20%)
- Amazon Prime/Warehouse continues to gain electronics share
- Manufacturer D2C (Apple Store, Samsung, Sony direct)
- Tariffs on Asian electronics imports compressing margins
- Recession: electronics demand is highly discretionary
- AI/digital disruption of in-store Geek Squad model
- Further store-traffic decline as showrooming accelerates
| SWOT Factor | Weight | Score (1–10) | Weighted Score | Implication |
|---|---|---|---|---|
| Strengths | 30% | 7.0 | 2.10 | Resilient cash generation, shareholder returns, market position |
| Weaknesses | 25% | 6.0 | 1.50 | Revenue decline, thin margins, leverage |
| Opportunities | 25% | 5.5 | 1.38 | Real but uncertain; Health upside is long-dated |
| Threats | 20% | 6.5 | 1.30 | Structural and cyclical risks are material |
| Total SWOT Score | 100% | 6.28 / 10 | Moderate quality business at a fair price |
Bear, Base & Bull Intrinsic Value Scenarios
Bear Case
$48–55
Assumptions: Revenue declines to $37–38B by FY2029. Operating margin compresses to 2.5%. FCF falls to $700–800M. Dividend cut by 25%. WACC 10.5%. Terminal growth 0%. Earnings recovery stalls; P/E remains compressed at 9–10x on $5 normalised EPS.
Trigger: Deep US recession, major tariff disruption, or Amazon launching a competing in-home tech-support service at scale.
Base Case
$72–82
Assumptions: Revenue stabilises $41–43B. Operating margin recovers to 3.3–3.6%. FCF $1.1–1.4B. Dividend maintained and growing 2%/yr. WACC 9.5%. Terminal growth 0.5%. EPS recovers to $6.00–6.60 by FY2027 (guidance midpoint). Market re-rates to 13–14x forward earnings.
Trigger: Stable macro, AI device refresh cycle supports modest revenue recovery.
Bull Case
$100–115
Assumptions: Revenue recovers to $44–46B driven by AI-PC and connected-home cycles. BBY Health generates $2–3B revenue with 15% margins. Operating margin returns to 4.5%+. FCF grows to $1.8–2.0B. Multiple expands to 16–18x on EPS of $7.50+. WACC 8.5%.
Trigger: Successful execution of Health pivot; AI supercycle in hardware; continued buybacks compounding EPS growth.
Entry & Exit Framework
Entry conditions: Buy aggressively below $60 (30%+ discount to base-case IV, >8% FCF yield). Begin accumulating at $62–68. Avoid chasing above $78 without clear evidence of revenue stabilisation or Health segment inflection.
Economic conditions for entry: Ideal entry during a consumer-discretionary sell-off (VIX above 25, consumer confidence below 90), Fed rate-cut cycle beginning, tariff uncertainty resolving. Best Buy tends to overshoot to the downside in risk-off environments, creating value.
Exit conditions: Trim at $95–100 (near bull-case IV); sell all above $110 unless fundamentals justify higher. Also sell if: FCF falls below $800M for two consecutive years; dividend is cut; Amazon aggressively enters Geek Squad territory; or management makes a large dilutive acquisition.
Buy Price by Return Target (16-Year Horizon)
Based on base-case terminal value of $90 (FY2042 estimate, including dividends reinvested at 50% of dividends paid per year assumed at $3.80/sh growing 1%/yr). All prices represent maximum entry price to achieve the target annualised return.
| Target Annual Return | Total Return (16 yr) | Max Buy Price |
|---|---|---|
| 5% per year | ~116% | $82.00 |
| 6% per year | ~154% | $72.00 |
| 7% per year | ~196% | $63.00 |
| 8% per year | ~244% | $55.00 |
| 9% per year (target) | ~300% | $48.00 |
| 10% per year | ~362% | $42.00 |
Note: At current price of $75.13, Best Buy does NOT meet the 9%/yr target over 16 years under the base case. The required entry price is approximately $48. The stock must be bought materially cheaper, or the bull case must materialise, for this return target to be achievable. The dividend yield (~5%) meaningfully contributes but does not close the gap alone.
Buy Price for 9% Annual Return by Time Horizon
| Holding Period | Required Total Return | Max Buy Price |
|---|---|---|
| 5 years | ~54% | $58.00 |
| 7 years | ~83% | $55.00 |
| 10 years | ~137% | $50.00 |
| 12 years | ~181% | $48.00 |
| 14 years | ~233% | $46.00 |
| 16 years | ~300% | $48.00 |
The 5-year horizon actually permits a slightly higher entry price because dividend income is weighted more heavily relative to the terminal value. For the 9% target over a medium 5–7 year hold, the target entry is $55–58, still well below the current $75.13.
Trim and Exit Price Levels
| Action | Price Level | Rationale |
|---|---|---|
| Begin trimming (25%) | $90–95 | Approaching bull-case fair value; reduce exposure to risk |
| Trim further (50%) | $100–105 | Stock fully valued on FCF and earnings multiple basis |
| Sell all | $110–115 | Bull-case intrinsic value; limited further upside without major fundamental change |
| Stop loss (risk mgmt) | $40–42 | Bear-case IV reached; review thesis for fundamental deterioration |
Risk Score
Scored 1 (low risk) to 10 (high risk). Weighted score below 4 = low risk; 4–6 = moderate; above 6 = high.
- Financial Stability (x0.30): 4.5
- Earnings Volatility (x0.20): 7.0
- Business Model Risk (x0.20): 6.5
- Macro Sensitivity (x0.15): 6.5
- Market Risk (x0.15): 5.5
| Component | Raw Score | Weight | Contribution |
|---|---|---|---|
| Financial Stability | 4.5 | 30% | 1.35 |
| Earnings Volatility | 7.0 | 20% | 1.40 |
| Business Model Risk | 6.5 | 20% | 1.30 |
| Macro Sensitivity | 6.5 | 15% | 0.98 |
| Market Risk | 5.5 | 15% | 0.83 |
| Composite Risk Score | 5.86 / 10 |
Implication: A composite score of 5.86 places Best Buy in the moderate-to-high risk band. The dominant risk drivers are earnings volatility (EPS has swung from $9.84 to $4.28 in four years) and business model risk (structural e-commerce disruption). Financial stability is the relative bright spot, anchored by consistent FCF. This score confirms that BBY is not a low-risk value play; it requires a significant margin of safety and is unsuitable for investors with low risk tolerance.
Opportunity Score
Scored 1 (low opportunity) to 10 (high opportunity). Score above 6.5 = attractive opportunity.
- Growth Potential (x0.30): 3.5
- Unit Economics (x0.20): 6.5
- Competitive Advantage (x0.20): 5.5
- Valuation Asymmetry (x0.20): 6.0
- Catalysts (x0.10): 5.5
| Component | Raw Score | Weight | Contribution |
|---|---|---|---|
| Growth Potential | 3.5 | 30% | 1.05 |
| Unit Economics | 6.5 | 20% | 1.30 |
| Competitive Advantage | 5.5 | 20% | 1.10 |
| Valuation Asymmetry | 6.0 | 20% | 1.20 |
| Catalysts | 5.5 | 10% | 0.55 |
| Composite Opportunity Score | 5.20 / 10 |
Implication: A score of 5.20 indicates a below-average opportunity at today’s price. The principal drag is weak growth potential — BBY is a mature, declining-revenue business without a high-confidence growth driver. Unit economics (ROIC 24.8%, FCF yield 8%) are attractive, but they are already partly reflected in the valuation. The opportunity score would improve materially if the stock fell to $55–60, as valuation asymmetry would jump to 8–9/10.
Company Classification
| Framework | Classification | Reasoning |
|---|---|---|
| Business Stage | STABLE / DECLINING | Revenue has declined 20% from its FY2022 peak and has stabilised near $41–42B. The core electronics retail business is in slow structural decline offset partially by services growth. Classify as “stable/declining” rather than outright declining, as FCF is healthy and the business has found a floor. |
| Peter Lynch Classification | Slow Grower / Asset Play | Lynch would categorise Best Buy as a “slow grower” — a large, mature company growing in line with (or below) GDP. He might also see an “asset play” angle through the Geek Squad brand value and real estate optionality. Lynch would be attracted by the sub-1.0 PEGY on a near-term basis and the consistent dividend, but deterred by the EPS trend and the structural threat from Amazon. He would likely require the stock below $60 before buying, citing the need for a comfortable PEGY margin. |
| Charlie Munger Classification | Mediocre Business at a Fair Price | Munger’s famous line is “a wonderful business at a fair price is better than a fair business at a wonderful price.” He would classify Best Buy as a fair-to-mediocre business — adequate returns, no durable pricing power, fighting Amazon on its home turf. Munger would likely avoid it entirely, preferring to wait for a truly exceptional business. He would note that the goodwill impairment and declining operating leverage are signals of a business whose competitive position is eroding, not strengthening. He would not buy Best Buy regardless of price unless the Health segment became a demonstrably superior business within the holding company. |
Data Used vs. Ignored
| Used in Analysis | Ignored / De-weighted |
|---|---|
| FY2022–FY2026 revenue, gross profit, operating income, net incomeEPS diluted (all years)Free cash flow (all years)EBITDA and EBITDA marginOperating cash flow and capexCash, debt, current ratio, net debtShares outstanding and share changeROE (37%), ROIC (24.8%)Beta (1.37)Dividend per share and yieldForward EPS guidance ($6.20–$6.60)EV/EBITDA (5.8x), EV/FCF (12x)Goodwill impairment (FY2025)Gross margin stability (~22%) | Quarterly data (used only as context; annual data drives thesis)Book value per share (distorted by lease liabilities; not meaningful for retail)P/B ratio (same reason)Trailing PEG (EPS trend is negative; metric not reliable)Revenue per store (directionally useful but not central)SG&A as % of revenue (relatively stable; minor factor)Interest income/expense (immaterial to thesis)Tax rate variability (FY2025 spike to 28.7% was one-off; normalized at 24%)Pension obligations (immaterial for BBY) |
Red Flag Scan
🚩 Declining revenue: Revenue down 20% from FY2022 peak — structural, not cyclical only.
⚠️ Rising operating lease debt: Total leases of $2.96B growing slowly; manageable but warrants monitoring.
🚩 Earnings volatility: EPS swung from $9.84 to $4.28 in four years — high dispersion undermines confidence in normalised earnings.
✅ Goodwill: Reduced to $790M after FY2025 impairment; risk partially cleaned up.
✅ Share dilution: None — shares have declined 16% since FY2022. Management returning capital.
✅ Serial acquisitions: None of significance. Capital disciplined.
⚠️ Overreliance on product cycle: Revenue is hostage to consumer electronics refresh cycles (TV supercycles, PC upgrade waves), which are lumpy.
🚩 Moat erosion: Amazon’s grocery and electronics growth, combined with manufacturer direct channels, is structurally reducing BBY’s relevance as an intermediary.
✅ Free cash flow: Positive and recovering. No alarm.
✅ Management compensation: Aligned with long-term value via stock incentives; no evidence of excessive pay relative to performance.
⚠️ Accounting complexity: GAAP vs. adjusted EPS gap (FY2025: GAAP $4.28 vs. adjusted guidance-implied ~$6.00) due to goodwill impairment. Monitor going forward.
Final Summary & Verdict
Best Buy is the last large-format specialist electronics retailer in North America, generating $41.7B in revenue, $1.26B in free cash flow, and paying a dividend yield above 5%. The business is operationally sound, capital-efficient (ROIC 24.8%), and managed by a team that prioritises shareholder returns through buybacks and dividends rather than empire-building. The FCF yield of approximately 8% is high and provides a floor of value.
However, the stock fails the 9% annual return test at $75.13. The required entry price for a 9% 16-year annualised return under the base case is approximately $48. The business faces genuine structural headwinds from Amazon and manufacturer direct channels that make a return to $50B+ revenue implausible without a major catalyst. The margin of safety at current prices is thin.
Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. Always perform your own due diligence or consult with a financial advisor before making investment decisions.
